Bettina M. Cockroft - 05 May 2023 Form 4/A - Amendment Insider Report for CNS Pharmaceuticals, Inc. (CNSP)

Role: Director
Signature: /s/ Christopher Downs, Attorney-in-fact
Issuer symbol: CNSP
Transactions as of: 05 May 2023
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 10 Aug 2023, 21:14:44 UTC
Date Of Original Report: 09 May 2023
Previous filing: 09 May 2023
Next filing: 12 Jun 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CNSP	Option to purchase common stock	Award		+2,099			2,099	05 May 2023	Common Stock	2,099	$1.67	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The options set forth in this table vest in 36 equal monthly installments succeeding the issuance date, or May 5, 2023, subject to the grantee's continued service on the Company's Board of Directors on each vesting date.
F2	The options were issued in connection with the reporting person's Board of Director services to the Company.

Remarks:

This amendment is being filed to correct the number of shares underlying the options set forth in Table II from 8,300 shares of common stock to 2,099 shares of common stock, and to correct the expiration date of the options from May 5, 2023 to May 5, 2033.